← stocks-llm New chat

LUCID DIAGNOSTICS INC (LUCD) — insider trading

Health Care · NASDAQ

LUCID DIAGNOSTICS INC (LUCD) has 10 reported SEC Form 4 insider transactions in our data, including 1 open-market purchase among the most recent 10 (latest 2026-05-20).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-05-20 Matheis Dennis Director Open-market purchase 245,000 $1.00 $245.3K Form 4
2026-02-20 MCGRATH DENNIS M Officer (Chief Financial Officer) Grant / award / vesting 470,000 $0.00 $0 Form 4
2026-02-20 Cox James L Director Grant / award / vesting 123,000 $0.00 $0 Form 4
2026-02-20 Lapidus Stanley Director Grant / award / vesting 123,000 $0.00 $0 Form 4
2026-02-20 PALUMBO JOHN R Director Grant / award / vesting 123,000 $0.00 $0 Form 4
2026-02-20 SOKOLOV JACQUE J Director Grant / award / vesting 123,000 $0.00 $0 Form 4
2026-02-20 Sparks Ronald M Director Grant / award / vesting 123,000 $0.00 $0 Form 4
2026-02-20 White Debra Director Grant / award / vesting 123,000 $0.00 $0 Form 4
2026-02-20 Matheis Dennis Director Grant / award / vesting 123,000 $0.00 $0 Form 4
2026-02-20 Aklog Lishan Director, Officer (Chief Executive Officer) Grant / award / vesting 2,170,000 $0.00 $0 Form 4

Ask the chat about LUCD's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: LUCID DIAGNOSTICS INC (LUCD).

Last updated 2026-05-20 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.